Max Robotics — Global Service Robot Directory + US Certification

About

Shaoxi Niu is a pioneering urologic surgeon whose work centers on robotic surgery for complex urologic cancers, particularly renal cell carcinoma with inferior vena cava (IVC) thrombus and prostate cancer. His most impactful contribution is the development and validation of robot-assisted IVC thrombectomy for Level III–IV thrombi, a procedure traditionally requiring open surgery. His 2019 paper detailing the step-by-step technique and 1-year outcomes has garnered 99 citations, establishing a new standard for minimally invasive management of this life-threatening condition. Niu further advanced the field by creating a decision-making scheme for Level II thrombi, comparing cavectomy versus thrombectomy in a multi-institutional analysis (54 citations). Beyond renal surgery, he has challenged diagnostic paradigms with a prospective trial (2024, 19 citations) evaluating radical prostatectomy without prior biopsy in patients selected by PSMA PET/MRI, potentially reducing unnecessary procedures. Notably, Niu is at the forefront of surgical robotics innovation, leading multicenter randomized trials demonstrating the non-inferiority of the domestic MP1000 system versus the da Vinci Si for partial nephrectomy and prostatectomy, and pioneering the first multicenter randomized trial of urological telesurgery (2026). His work is reshaping the boundaries of what is possible with robotic platforms.